000650SZSE

Announcement on Wholly-Owned Subsidiary Obtaining Drug Registration Certificate for Qingfei Tang Granules

Renhe Pharmacy Co., Ltd.··2 pages

✨ AI Summary

This announcement details that the company's wholly-owned subsidiary, Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd., has received a drug registration certificate from the National Medical Products Administration for Qingfei Tang Granules. This approval allows the product to be marketed, enriching the company's product line and enhancing market competitiveness. The company has invested approximately RMB 8 million in R&D for this product.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 000650 Stock Abbreviation: Renhe Pharmaceutical Announcement No.: 2026-029

Renhe Pharmaceutical Co., Ltd. Announcement on Wholly-Owned Subsidiary Obtaining Drug Registration Certificate for Qingfei Tang Granules

The Company and its directors, supervisors, and senior management guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are not aware of any false representations, misleading statements, or material omissions.

Recently, Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. ("the Company"), a wholly-owned subsidiary of Renhe Pharmaceutical Co., Ltd. ("the Company"), received a "Drug Registration Certificate" for Qingfei Tang Granules issued by the National Medical Products Administration ("NMPA"). The relevant situation is hereby announced as follows:

I. Basic Information of the Drug

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.